Grant: Discovery Grants Program - Individual
McMaster University
$22,500.00
The effects of environmental interventions on basal ganglia functioning
FY 2007-08
Summary
The basal ganglia are a set of brain structures that act as a feedback circuit to modify the functioning of the cerebral cortex. Proper functioning of the basal ganglia is required for the selection and execution of programmed sequences of movements ("motor programmes"). The neurotransmitter dopamine plays a particularly crucial role in the regulation of basal ganglia function. Factors which alter dopaminergic signaling within the basal ganglia interfere with the ability to access motor programmes and thereby impair an individual's ability to respond effectively to events in the external world. It is known that the intrauterine environment and the early life environment can have long-term behavioural effects. The present proposal aims to study whether these behavioural effects might be mediated, at least in part, by changes in the basal ganglia. The proposed studies should help to clarify the neural mechanisms by which early life events are able to exert long-lasting effects on behaviour. They should also indicate whether intrauterine exposure to antipsychotic medication may constitute a risk factor for the later development of Parkinson's disease.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
138523-2006
Name nom
Mazurek, Michael
Department département
Psychiatry and Behavioural Neurosciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
22500
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6309
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience --learning
Research subject fr
Neurologie du comportement -- apprentissage
Partie
2
Nb partie
2
Application title
The effects of environmental interventions on basal ganglia functioning
Keyword
NA
Application summary
The basal ganglia are a set of brain structures that act as a feedback circuit to modify the functioning of the cerebral cortex. Proper functioning of the basal ganglia is required for the selection and execution of programmed sequences of movements ("motor programmes"). The neurotransmitter dopamine plays a particularly crucial role in the regulation of basal ganglia function. Factors which alter dopaminergic signaling within the basal ganglia interfere with the ability to access motor programmes and thereby impair an individual's ability to respond effectively to events in the external world. It is known that the intrauterine environment and the early life environment can have long-term behavioural effects. The present proposal aims to study whether these behavioural effects might be mediated, at least in part, by changes in the basal ganglia. The proposed studies should help to clarify the neural mechanisms by which early life events are able to exert long-lasting effects on behaviour. They should also indicate whether intrauterine exposure to antipsychotic medication may constitute a risk factor for the later development of Parkinson's disease.